{
  "id": 5559035,
  "title": "Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test",
  "url": "https://urgent.news/2026/09/04/grail-stock-jumps-in-august-as-fda-schedules-a-key-meeting-for-its-5559035",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T12:10:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/grail-stock-jumps-august-fda-schedules-key-meeting-its-galleri-cancer-test"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsFDA approval is crucial for Galleri's adoption by insurers.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test",
        "url": "https://urgent.news/2026/09/04/grail-stock-jumps-in-august-as-fda-schedules-a-key-meeting-for-its",
        "published": "2026-09-04T11:50:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}